Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Electronic study for anastrozole pharmacovigilance evaluation

Trial Profile

Electronic study for anastrozole pharmacovigilance evaluation

Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2008

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Early breast cancer
  • Focus Adverse reactions
  • Sponsors AstraZeneca
  • Most Recent Events

    • 25 Jul 2008 The actual completion date has been identified as Jul 2008, as reported by ClinicalTrials.gov.
    • 23 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top